Evidence map›Paper›PMID 39273521›Full record

ArticleInternational journal of molecular sciences2024

Non-Negative Matrix Tri-Factorization for Representation Learning in Multi-Omics Datasets with Applications to Drug Repurposing and Selection.

Letizia Messa, Carolina Testa, Stephana Carelli, Federica Rey, Emanuela Jacchetti, Cristina Cereda, Manuela Teresa Raimondi, Stefano Ceri, Pietro Pinoli

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Letizia MessaDepartment of Electronics, Information and Bioengineering (DEIB), Politecnico di Milano, 20133 Milan, Italy.ORCID 0000-0003-1718-2229
Carolina TestaDepartment of Electronics, Information and Bioengineering (DEIB), Politecnico di Milano, 20133 Milan, Italy.ORCID 0000-0002-6059-0204
Stephana CarelliCenter of Functional Genomics and Rare Diseases, Buzzi Children's Hospital, 20154 Milan, Italy.ORCID 0000-0003-4603-396X
Federica ReyPediatric Clinical Research Center "Fondazione Romeo ed Enrica Invernizzi", Department of Biomedical and Clinical Sciences, Università degli Studi di Milano, 20157 Milan, Italy.ORCID 0000-0001-7944-3143
Emanuela JacchettiDepartment of Chemistry, Materials and Chemical Engineering "Giulio Natta", Politecnico di Milano, 20133 Milan, Italy.ORCID 0000-0001-5990-001X
Cristina CeredaCenter of Functional Genomics and Rare Diseases, Buzzi Children's Hospital, 20154 Milan, Italy.ORCID 0000-0001-9571-0862
Manuela Teresa RaimondiDepartment of Chemistry, Materials and Chemical Engineering "Giulio Natta", Politecnico di Milano, 20133 Milan, Italy.ORCID 0000-0003-2585-7206
Stefano CeriDepartment of Electronics, Information and Bioengineering (DEIB), Politecnico di Milano, 20133 Milan, Italy.ORCID 0000-0003-0671-2415
Pietro PinoliDepartment of Electronics, Information and Bioengineering (DEIB), Politecnico di Milano, 20133 Milan, Italy.ORCID 0000-0001-9786-2851

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The vast corpus of heterogeneous biomedical data stored in databases, ontologies, and terminologies presents a unique opportunity for drug design. Integrating and fusing these sources is essential to develop data representations that can be analyzed using artificial intelligence methods to generate novel drug candidates or hypotheses. Here, we propose Non-Negative Matrix Tri-Factorization as an invaluable tool for integrating and fusing data, as well as for representation learning. Additionally, we demonstrate how representations learned by Non-Negative Matrix Tri-Factorization can effectively be utilized by traditional artificial intelligence methods. While this approach is domain-agnostic and applicable to any field with vast amounts of structured and semi-structured data, we apply it specifically to computational pharmacology and drug repurposing. This field is poised to benefit significantly from artificial intelligence, particularly in personalized medicine. We conducted extensive experiments to evaluate the performance of the proposed method, yielding exciting results, particularly compared to traditional methods. Novel drug-target predictions have also been validated in the literature, further confirming their validity. Additionally, we tested our method to predict drug synergism, where constructing a classical matrix dataset is challenging. The method demonstrated great flexibility, suggesting its applicability to a wide range of tasks in drug design and discovery.

Indexed as

Drug RepositioningAlgorithmsArtificial IntelligenceComputational BiologyDrug DiscoveryHumansMachine LearningMultiomicsdata integrationdrug repurposingdrug selectionmachine learningpersonalized medicinerepresentation learning

Identifiers

PMID39273521
PMCPMC11394968

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.